KAPA Stock Analysis: Buy, Sell, or Hold?
KAPA - Kairos Pharma, Ltd.
$0.29
-0.01 (-1.73%)
▼
5d:
-14.96%
30d:
-2.65%
90d:
-47.54%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When KAPA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: KAPA is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: KAPA is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: KAPA is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.30 to $0.35.
Technical Outlook: Technically, KAPA is in a strong downtrend. The price is currently testing key support at $0.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KAPA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+2313.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KAPA is in a strong downtrend. The price is currently testing key support at $0.29. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KAPA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $7.00 (+2313.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.30 -
$0.35
Company Quality Score
35/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2313.8% below Wall St target ($7.00)
- WARNING: Composite score 35/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.30 -
$0.35
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.29
Resistance Level
$0.38
Current Trend
Strong Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.43
Wall Street Target
$7.00
(+2313.8%)
Share & Embed Analysis
Last updated: August 24, 2026 2:13 AM ET
Data refreshes hourly during market hours. Next update: 3:13 AM
Data refreshes hourly during market hours. Next update: 3:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KAPA showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 51 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
